Pharma M&A: Agile Shouldn’t Mean Ad Hoc
by McKinsey & Company
Under pressure to be active acquirers, some pharmaceutical and medical-products companies may be neglecting best practices. Here’s where they can most improve. The spate of recent megamergers among both pharmaceutical and medical-products (PMP) companies has made for eye-opening headlines, not just for the supersizing of these industry-consolidating deals, but also because it seemed to mark a break from the industry’s usual pattern of M&A. […] Read more
